Corrigendum to "Identifies microtubule-binding protein CSPP1 as a novel cancer biomarker associated with ferroptosis and tumor microenvironment" [Comput Struct Biotechnol J 20 (2022) 3322-3335]

Wenwen Wang,Jingjing Zhang,Yuqing Wang,Yasi Xu,Shirong Zhang

DOI: https://doi.org/10.1016/j.csbj.2023.10.048

2023-11-01

Abstract:[This corrects the article DOI: 10.1016/j.csbj.2022.06.046.].

What problem does this paper attempt to address?

Correction to: Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells

Wenxing Chen,Yanhong Pan,Siliang Wang,Yuping Liu,Guangying Chen,Liang Zhou,Chao Zhang,Wenting Ni,Aiyun Wang,Yin Lu,Shile Huang

DOI: https://doi.org/10.1186/s12885-019-5458-y

IF: 4.638

2019-01-01

BMC Cancer

Abstract:Following publication of the original article [1], the author noticed the following errors in the article.
Corrigendum: Identification of Microtube-Associated Biomarkers in Diffuse Large B-cell Lymphoma and Prognosis Prediction.

Wenqi Wu,Su Liu,Linyan Tian,Cheng Li,Yanan Jiang,Jinhuan Wang,Yangyang Lv,Jing Guo,Donghui Xing,Yixin Zhai,Huimeng Sun,Yuhang Li,Luying Zhang,Xiang He,Kaiping Luo,Hongjie Zhan,Zhigang Zhao

DOI: https://doi.org/10.3389/fgene.2023.1180076

IF: 3.7

2023-01-01

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.1092678.].
Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer

Xin Tian,Lina Wu,Min Jiang,Zhenyong Zhang,Rong Wu,Jianing Miao,Caigang Liu,Song Gao

DOI: https://doi.org/10.3389/fonc.2022.793448

IF: 4.7

2022-04-06

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.641399.].

oncology
Author correction to “Coordinated regulation of BACH1 and mitochondrial metabolism through tumor targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy” [Acta Pharmaceutica Sinica B 12 (2022) 3934–3951]

Xuan Yang,Yalong Wang,Junke Zhao,Hehui Rong,Yujun Chen,Mengting Xiong,Xiaoxing Ye,Shihui Yu,Haiyan Hu

DOI: https://doi.org/10.1016/j.apsb.2023.08.006

IF: 14.903

2023-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.06.009.].
Corrigendum: The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma

Wan He,Gengpeng Lin,Chaohu Pan,Wenwen Li,Jing Shen,Yangli Liu,Hui Li,Dongfang Wu,Xuejia Lin

DOI: https://doi.org/10.3389/fgene.2022.879922

IF: 3.7

2022-03-11

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.761681.].

genetics & heredity
Author correction to “Coordinated regulation of BACH1 and mitochondrial metabolism through tumor targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy” [Acta Pharmaceutica Sinica B (2022) 12 (10) 3934–3951]

Xuan Ye,Yalong Wang,Junke Zhao,Hehui Rong,Yujun Chen,Mingrui Xiong,Xiaoxing Ye,Shihui Yu,Haiyan Hu

DOI: https://doi.org/10.1016/j.apsb.2023.08.006

IF: 14.903

2023-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.06.009.].
Correction: Corrigendum: BCIP: A Gene-Centered Platform for Identifying Potential Regulatory Genes in Breast Cancer

Jiaqi Wu,Shuofeng Hu,Yaowen Chen,Zongcheng Li,Jian Zhang,Hanyu Yuan,Qiang Shi,Ningsheng Shao,Xiaomin Ying

DOI: https://doi.org/10.1038/srep46913

IF: 4.6

2017-01-01

Scientific Reports

Abstract:This corrects the article DOI: 10.1038/srep45235.
Corrigendum: Molecular Portrait of GIST Associated With Clinicopathological Features: A Retrospective Study With Molecular Analysis by a Custom 9-Gene Targeted Next-Generation Sequencing Panel

Haoran Qian,Na Yan,Xiaotong Hu,Junchang Jiang,Zhengzheng Cao,Dan Shen

DOI: https://doi.org/10.3389/fgene.2022.945357

IF: 3.7

2022-06-28

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.864499.].

genetics & heredity
Corrigendum: Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies

Jun Cao,Mengdi Zhang,Bin Wang,Long Zhang,Fangfang Zhou,Meiyu Fang

DOI: https://doi.org/10.3389/fonc.2021.745052

IF: 4.7

2021-08-17

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.658552.].

oncology
Corrigendum to "Gene mutations in newly diagnosed multiple myeloma patients detected by next-generation sequencing technology" [ Cancer Pathog Ther. 2024;2:205-211]

Yutong Wang,Mengzhen Wang,Bin Chu,Minqiu Lu,Lei Shi,Shan Gao,Yuan Chen,Qin Yan,Na Ji,Li Bao

DOI: https://doi.org/10.1016/j.cpt.2024.09.002

2024-09-14

Abstract:[This corrects the article DOI: 10.1016/j.cpt.2023.12.004.].
Corrigendum: Cuproptosis Key Gene FDX1 is a Prognostic Biomarker and Associated with Immune Infiltration in Glioma.

Hanwen Lu,Liwei Zhou,Bingchang Zhang,Yuanyuan Xie,Huiyin Yang,Zhanxiang Wang

DOI: https://doi.org/10.3389/fmed.2023.1244638

IF: 3.9

2023-01-01

Frontiers in Medicine

Abstract:[This corrects the article DOI: 10.3389/fmed.2022.939776.].
Corrigendum: A microarray data analysis investigating the pathogenesis and potential biomarkers of autophagy and ferroptosis in intervertebral disc degeneration

Wenhao Kuang,Cong Jiang,Cheng Yu,Jinwei Hu,Yang Duan,Zhong Chen

DOI: https://doi.org/10.3389/fgene.2023.1236744

2023-09-05

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.1090467.].
Erratum: Author Correction to "Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy" [acta Pharm Sin B (2022) 4224-4234].

Zekun Li,Yongchun Pan,Shiyu Du,Yayao Li,Chao Chen,Hongxiu Song,Yueyao Wu,Xiaowei Luan,Qin Xu,Xiaoxiang Guan,Yujun Song,Xin Han

DOI: https://doi.org/10.1016/j.apsb.2023.09.002

IF: 14.903

2023-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.06.016.].
Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Haibo Xing,Mengting Tong,Jing Wang,Hanqing Hu,Chongya Zhai,Chunhui Huang,Da Li

DOI: https://doi.org/10.1155/2022/9767389

2022-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2018/3195025.].
Corrigendum to “clinical Significance of the Decreased Expression of Hsa_circ_001242 in Oral Squamous Cell Carcinoma”

Shuai Sun,Bowen Li,Yufan Wang,Xiang Li,Panpan Wang,Feng Wang,Wei Zhang,Hongyu Yang

DOI: https://doi.org/10.1155/2019/2434063

2019-01-01

Disease Markers

Abstract:[This corrects the article DOI: 10.1155/2018/6514795.].
Erratum: Author correction to 'VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity' [Acta Pharm Sin B 11 (2021) 420-433]

Pengzhao Shang,Rui Gao,Yijia Zhu,Xiaorui Zhang,Yang Wang,Minji Guo,Hui Peng,Min Wang,Juan Zhang

DOI: https://doi.org/10.1016/j.apsb.2024.02.014

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2020.09.008.].
Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis

Xu-Sheng Liu,Lu-Meng Zhou,Ling-Ling Yuan,Yan Gao,Xue-Yan Kui,Xiao-Yu Liu,Zhi-Jun Pei

DOI: https://doi.org/10.3389/fimmu.2021.751004

IF: 7.3

2021-08-31

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.724741.].

immunology
Corrigendum: MicroRNA-16-1-3p Represses Breast Tumor Growth and Metastasis by Inhibiting PGK1-Mediated Warburg Effect.

Tianxing Ye,Yingchun Liang,Deyu Zhang,Xuewu Zhang

DOI: https://doi.org/10.3389/fcell.2021.649787

IF: 5.5

2021-01-01

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2020.615154.].
Corrigendum: Dissecting the single-cell transcriptome network of immune environment underlying cervical premalignant lesion, cervical cancer and metastatic lymph nodes

Chunbo Li,Keqin Hua

DOI: https://doi.org/10.3389/fimmu.2024.1386072

IF: 7.3

2024-02-23

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.897366.].

immunology
Corrigendum: Sanguisorba officinalis L. Suppresses Triple-Negative Breast Cancer Metastasis by Inhibiting Late-Phase Autophagy via Hif-1α/Caveolin-1 Signaling

Neng Wang,Gulizeba Muhetaer,Xiaotong Zhang,Bowen Yang,Caiwei Wang,Yu Zhang,Xuan Wang,Juping Zhang,Shengqi Wang,Yifeng Zheng,Fengxue Zhang,Zhiyu Wang

DOI: https://doi.org/10.3389/fphar.2021.810621

IF: 5.6

2022-01-06

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2020.591400.].

pharmacology & pharmacy

Corrigendum to "Identifies microtubule-binding protein CSPP1 as a novel cancer biomarker associated with ferroptosis and tumor microenvironment" [Comput Struct Biotechnol J 20 (2022) 3322-3335]

Correction to: Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells

Corrigendum: Identification of Microtube-Associated Biomarkers in Diffuse Large B-cell Lymphoma and Prognosis Prediction.

Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer

Author correction to “Coordinated regulation of BACH1 and mitochondrial metabolism through tumor targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy” [Acta Pharmaceutica Sinica B 12 (2022) 3934–3951]

Corrigendum: The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma

Author correction to “Coordinated regulation of BACH1 and mitochondrial metabolism through tumor targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy” [Acta Pharmaceutica Sinica B (2022) 12 (10) 3934–3951]

Correction: Corrigendum: BCIP: A Gene-Centered Platform for Identifying Potential Regulatory Genes in Breast Cancer

Corrigendum: Molecular Portrait of GIST Associated With Clinicopathological Features: A Retrospective Study With Molecular Analysis by a Custom 9-Gene Targeted Next-Generation Sequencing Panel

Corrigendum: Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies

Corrigendum to "Gene mutations in newly diagnosed multiple myeloma patients detected by next-generation sequencing technology" [ Cancer Pathog Ther. 2024;2:205-211]

Corrigendum: Cuproptosis Key Gene FDX1 is a Prognostic Biomarker and Associated with Immune Infiltration in Glioma.

Corrigendum: A microarray data analysis investigating the pathogenesis and potential biomarkers of autophagy and ferroptosis in intervertebral disc degeneration

Erratum: Author Correction to "Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy" [acta Pharm Sin B (2022) 4224-4234].

Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Corrigendum to “clinical Significance of the Decreased Expression of Hsa_circ_001242 in Oral Squamous Cell Carcinoma”

Erratum: Author correction to 'VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity' [Acta Pharm Sin B 11 (2021) 420-433]

Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis

Corrigendum: MicroRNA-16-1-3p Represses Breast Tumor Growth and Metastasis by Inhibiting PGK1-Mediated Warburg Effect.

Corrigendum: Dissecting the single-cell transcriptome network of immune environment underlying cervical premalignant lesion, cervical cancer and metastatic lymph nodes

Corrigendum: Sanguisorba officinalis L. Suppresses Triple-Negative Breast Cancer Metastasis by Inhibiting Late-Phase Autophagy via Hif-1α/Caveolin-1 Signaling